baber/WOPTO huggingface dataset:
Patent PT-627912-E (PT)
Inventor: DESAI NEIL P
IPC: A61K35/12
Filed: 1993-03-01
Abstract: This invention provides novel methods for the formation of biocompatible membranes around biological materials using photopolymerization of water soluble molecules. The membranes can be used as a covering to encapsulate biological materials or biomedical devices, as a "glue" to cause more than one biological substance to adhere together, or as carriers for biologically active species. Several methods for forming these membranes are provided. Each of these methods utilizes a polymerization system containing water-soluble macromers, species, which are at once polymers and macromolecules capable of further polymerization. The macromers are polymerized using a photoinitiator (such as a dye), optionally a cocatalyst, optionally an accelerator, and radiation in the form of visible or long wavelength UV light. The reaction occurs either by suspension polymerization or by interfacial polymerization. The polymer membrane can be formed directly on the surface of the biological material, or it can be formed on material, which is already encapsulated.
Patent PT-749961-E (PT)
Inventor: PONCEBLANC HERVE
IPC: C07B61/00
Filed: 1996-06-19
Abstract: Vapour phase prepn. of methyl mercaptan from methanol and hydrogen sulphide uses an alkali carbonate/alumina catalyst at below 350 degrees C. The catalyst is claimed per se. The alkali carbonate is of sodium, cesium or pref. potassium and it is deposited on the alumina in an amt. of 2-20% (pref. 6.4) wt.%. The reaction is carried out at 230-330 (pref. 280-310) degrees C and at a pressure of 8-15 bar. The hydrogen sulphide : methanol molar ratio is 1.5-2.5. The catalyst is dispersed in a system contg. at least 3 reactors.
Patent PT-797087-E (PT)
Inventor: DOGE KLAUS
IPC: B63B71/20
Filed: 1997-03-20
Abstract: The apparatus separates the topmost water layer from the main flow by a blade and feeds it to a calming stretch. The main flow which is provided with an interception sieve (6) is deflected downwards by a curve (10). The lower side of the blade (4) runs parallel to the water surface of the measurement stretch (7). The upper side of the blade has a small slope and forms the base for the flood chamber (5) arranged over the blade. The base slopes towards the front edge of the blade. The front edge of the blade is rounded with a radius (R). The sieve runs through the flow region in front of the front edge of the blade and extends over the water reflection. Preferably the slope of the blade upper side and thus also the base of the chamber is about 2 to 5 deg. to the front edge of the blade.
Patent PT-827701-E (PT)
Inventor: SEIDEL JOACHIM
IPC: A45B25/14
Filed: 1997-07-01
Abstract: The umbrella handle (12) incorporates two releases (A1,A2) for opening and closing respectively and which are operated by a sliding release button (11). The release (A2) is in the form of a unit with spring-tensioned (19) unlocking-slide-piece (14,15) and a detent pawl (16) in the form of a two-sided lever. The telescopic umbrella-stick (1) has a crown (4), a slide-piece (5) and a canopy structure (2). Two spring drive units (F1,F2) have a compression spring (F1') and tension springs (F2') respectively. A cable pull (S) has a cable (S') with one end co-operating with the release mechanism by means of a bar (8) movably mounted in the umbrella stick and a pawl (9) on it. The pawl is locked by a hooked lug (9b) touching a tubular locking piece (10) with hollowed out cavity (10a).
Patent PT-958351-E (PT)
Title: Chimeric target molecules having a regulatable activity
Inventor: LEGENDRE DANIEL
IPC: C12N15/09
Filed: 1997-11-26
Abstract: The present invention relates to a chimeric target molecule having an activity which can be regulated or modulated by a binding molecule. The invention also relates to methods of using the chimeric target molecule to detect the presence and/or amount of a desired analyte in a sample. The analyte is a binding molecule, or a competitor of a binding molecule, which binding molecule, upon binding to the target molecule, alters the activity of the target molecule in a detectable way. In one aspect of the invention, a binding molecule binds to the chimeric molecule, inactivating it. An analyte in a test sample competes and/or displaces the binding molecule from the chimera, reactivating it. The reappearance of activity in the presence of the analyte indicates its existence in the test sample existence and amount. Another aspect of the invention relates to a binding molecule which regulates a chimeric target molecule and methods of producing it.
Patent PT-859382-E (PT)
Inventor: LLEIDA RAFAEL RAGA
IPC: H01F27/40
Filed: 1998-01-20
Abstract: The transformer (15) has a magnetic core and primary and secondary coils contained within or are in contact with its casing (11). Within the casing, there is moulded resin (14) and pumped dielectric gas in the spaces between the coils. A disc (10) is held directly between the casing and its cover (12) which fixes on cover and forms a channel between the disc and the exterior of the casing. The cover is screwed onto the casing and a ring seal (13) is placed between the disc and the cover. The cover has a series of openings (19) to allow the gas to escape should the disc break. The casing may cover the whole of the core and the primary and secondary coils. Alternatively, it may be a single piece covering the part of the transformer necessary to form the channel between the core and coils and the disc.
Patent PT-981358-E (PT)
Inventor: BARLOZZARI TERESA
IPC: A61K38/08
Filed: 1998-03-09
Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.</PTEXT>
Patent PT-1002897-E (PT)
Inventor: FLECKEN PETER
IPC: D21B1/08
Filed: 1999-08-12
Abstract: Process and apparatus for separating compressed material containing paper fibers where the apparatus includes at least three hammer rollers arranged essentially in a same plane and each hammer roller includes rotatable hammers. The process includes rotating the rotatable hammers, transporting the material over the at least three hammer rollers in a transport direction essentially parallel to the plane and transverse to the axes of the rollers, breaking up the material into fine material and non-fine material, and separating the fine material from the non-fine material by allowing the fine material to pass through gaps formed between the hammer rollers. The apparatus includes a machine frame and a plurality of rotors arranged next to one another in the machine frame. Axes of the driven rotors are arranged to lie in at least one plane, and the rotors are positioned to form free gaps between the driven rotors. A delivery unit, positioned above the plurality of rotors, is adapted to deliver the compressed material to the plurality of rotors and a removal unit, positioned below the plurality of rotors, is adapted to remove the processed material. The plurality of rotors include hammer rollers having shafts coupled to rotatable hammers, and a driver is provided for driving at least some adjacent hammer rollers in a same rotational direction.
Patent PT-1108060-E (PT)
Title: Molecular differences between species of the m. tuberculosis complex
Inventor: BEHR MARCEL
IPC: C12Q1/68
Filed: 1999-08-10
Abstract: Specific genetic deletions are identified in mycobacteria isolates, including variations in the  M.tuberculosis  genome between isolates, and numerous deletions present in BCG as compared to  M.tb.  These deletions are used as markers to distinguish between pathogenic and avirulent strains, and as a marker for particular  M.tb  isolates. Deletions specific to vaccine strains of BCG are useful in determining whether a positive tuberculin skin test is indicative of actual tuberculosis infection. The deleted sequences may be re-introduced into BCG to improve the efficacy of the vaccination. Alternatively, the genetic sequence that corresponds to the deletion(s) is deleted from  M.bovis  or  M.tuberculosis  to attenuate the pathogenic bacteria.
Patent PT-1144757-E (PT)
Inventor: WENNBERG OLLE
IPC: D21C11/08
Filed: 1999-11-24
Abstract: A method to remove sulfides and other volatile contaminants from liquor vapor condensate in a pulp manufacturing process, where the mentioned liquor vapor condensate is fed into a stripper, which is part of a closed loop system including the stripper, a regenerative thermal oxidization process (RTO) and a SO2 scrubber, in which loop a gas is circulated, preferably air, and such components formed or stripped off, in this loop whereafter the circulating gas is stripped off sulfides and other volatile components from the liquor vapor condensate, whereafter the gas stream is fed into a RTO process, where the stripped off contaminants are combusted are under formation of SO2 and thereafter the SO2 enriched gas is led to a SO2 scrubber, where preferably alkali is used as absorption medium, and thereafter the circulating gas is returned back into the stripper.
Patent CA-2657861-F (CA)
Inventor: TASSE BRUNO
IPC: E04G5/00
Filed: 2009-03-18
Granted: 2009-08-28
Abstract: A scaffolding frame comprises a pair of spaced apart elongated vertical members having respective top and bottom ends thereof and at least one elongated horizontal member mounted at each longitudinal end thereof to a respective one of the vertical members. Each vertical member defines a respective opposite lateral side of the frame. The horizontal member comprises a depressed portion near each longitudinal end thereof. When a first such frame is stacked onto a second such frame, one depressed portion and one vertical member of the first frame respectively engage one vertical member and one depressed portion of the second frame.
Patent SG-85390-G (SG)
Title: Interpolating filter arrangement with irrational ratio between the input and the output sampling frequencies
IPC: H03H17/06
Filed: 1990-10-24
Abstract: Interpolating time-discrete filter arrangement for increasing the sampling frequency of a time-discrete signal from f<sub>1</sub> to f<sub>u</sub>, f<sub>u</sub> not being a rational multiple of f<sub>i</sub>. For the generation of the required filter coefficients this filter arrangement comprises clock pulse generators which produce input clock pulses ki(q) at a rate f<sub>i</sub> and output clock pulses ku(n) at a rate f<sub>u</sub>. It also comprises a coefficients generator (4) in which a deviation component d(q) is calculated which indicates the relationship between the time interval T<sub>d(q)</sub> located between an input clock pulse k<sub>i</sub> (q) and the immediately preceding or the immediately subsequent output clock pulse ku(n) and the time interval T<sub>u</sub>=1/f<sub>u</sub> between two consecutive output clock pulses ku(n). In response to this deviation component the filter coefficients generator produces W filter coefficients, the w<sup>th</sup> filter coefficient (w = 0, 1, 2, 3, ... W-1) being equal to a (d(q),w) and being defined by the expressionHerein the function h(v) represents the impulse response of a FIR filter and v a continuous variable in the interval -∞ < v < ∞.
Patent IE-35146-L (IE)
Title: Oestradiol derivative.
IPC: C07J1/00
Filed: 1971-04-20
Abstract: 1330072 The 3-cyclopentyl ether of 7α-methyl- 17α - ethynyl - estradiol CIBA - GEIGY AG 21 April 1971 [24 April 1970] 10428/71 Heading C2U The title compound is prepared by etherification of 7α-methyl-17α-ethynyl-estradiol, by reacting the diol or a salt thereof with a reactive ester of cyclopentanol, or by ethynylation with an acetylene metal compound of 3-cyclopentyloxy - 7α - methyl - 17 - oxo - #<SP>1,3,5(10)</SP> - estratriene. The novel steroid is stated to have estrogenic, uterotropic and blastocyte implantation inhibiting action, and it may be made up into pharmaceutical and veterinary compositions with suitable carriers. Specification 1,330,071 is referred to.
[GB1330072A]
Patent IE-790553-L (IE)
Title: Grinding tube mill.
IPC: B02C17/06
Filed: 1979-08-08
Abstract: A grinding tube mill has a composite diaphragm (5) at the outlet end of a grinding chamber (3). The diaphragm comprises a combination of a coarse grate (6) facing the grinding chamber (3) for retaining grinding bodies in the chamber, and, on the side of the grate remote from the chamber, a sieving screen (7) for sieving the ground product. The coarse grate has a plurality of openings (20) which constitute substantially the effective open area of the coarse grate. The intermediate space between the coarse grate and the sieving screen contains guiding members (21, 22) to guide coarse particles backwards to the grinding chamber (3) through one or more apertures (19) in the coarse grate allowing free passage of the coarse particles. 
[EP0003878A2]
Patent IE-44818-L (IE)
Title: Anthracycline antibiotics.
IPC: A61P31/04
Filed: 1977-04-14
Abstract: A novel anthracycline antibiotic complex designated herein as bohemic acid complex is produced by fermentation of Actinosporangium sp. A.T.C.C. 31127. The complex and two bioactive components designated marcellomycin and musettamycin exhibit antibiotic activity and inhibit the growth of various tumor systems in rodents.
[US4039736A]
Patent FI-820114-L (FI)
Inventor: NYLANDER ARTHUR
IPC: E01F9/04
Filed: 1982-01-14
Abstract: 1. Formation method for retro-reflective horizontal roadway marking, in which a marking product is applied on to the surface to be marked, characterised in that the surface of the said product is sprinkled before drying with a mixture of microspheres of glass treated for floatation and of microspheres of glass treated for adhesion to the marking product.
Patent FI-822722-L (FI)
Inventor: OHLENDORF HEINRICH-WILHELM
IPC: C07D403/12
Filed: 1982-08-05
Abstract: New 1-phenyl-2-aminocarbonylindole compounds are described which have the general formula I    <IMAGE>  I  where R1 is a hydrogen atom, or a lower alkyl, alkenyl, cycloalkylalkyl radical, R2 is a hydrogen atom or a lower alkyl radical, R3 is a hydrogen or halogen atom, or a lower alkyl, hydroxyl or lower alkoxy radical, R4 is a hydrogen or halogen atom, or a lower alkyl, hydroxyl or lower alkoxy radical, or, if R3 is a hydrogen atom, R4 may be a nitro or trifluoromethyl radical, or R3 and R4 together denote a methylenedioxy or ethylenedioxy radical, R5 has the meanings given for R3, R6 has the meanings given for R4, R7 is a hydrogen atom or, if R5 and R6 are lower alkoxy radicals, R7 may also be a lower alkoxy radical, R8 and R9 are each a hydrogen atom or a lower alkyl radical or, together with the nitrogen atom, form a heterocyclic group, and Z is an alkylene chain which is optionally substituted by hydroxyl. The compounds have pharmaceutical properties, in particular antiarrhythmic properties. The compounds may be in the form of the free bases or acid addition salts. Pharmaceutical compositions containing these compounds are described as is a method of preparing them. Valuable intermediates for the production of these compounds and methods of preparing the intermediates are also described.
Patent FI-844506-L (FI)
Inventor: PFOHL SIGBERG
IPC: C08F8/00
Filed: 1984-11-16
Abstract: 1. A process for the production of paper, cardboard and board having high dry strength, wet strength and alkali resistance by adding an aqueous polymer solution to the paper stock in an amount of from 0.1 to 5% by weight, based in each case on the solids, and draining the paper stock on a screen to form sheets, wherein the aqueous polymer solution used is a reaction product obtained by reacting (1) a homopolymer of a vinylimidazole of the formula I  see diagramm : EP0146000,P6,F1  where R**1 , R**2 and R**3 are each H or CH3 , and R**1 may furthermore be C2 H5 , C3 H7 or C4 H9 , or (2) a water-soluble copolymer of a) at least 5% by weight of a vinylimidazole of the formula I, b) up to 95% by weight of acrylamide and/or methacrylamide and, if desired, c) up to 30% by weight of acrylonitrile, methylenically unsaturated C3 -C5 - carboxylic acid or one of its esters, with epichlorhydrin in a ratio of from 0.02 to 2.9 moles of epichlorhydrin per molar equivalent of basic nitrogen in the homopolymer or copolymer, in the absence of a polyalkyleneimine.
Patent FI-853713-L (FI)
Inventor: ERREN KARL-HEINZ
IPC: D01D5/16
Filed: 1985-09-26
Abstract: A method of producing a flat polymeric yarn is disclosed which includes the steps of melt spinning a polymer to form a plurality of running filaments, combining the filaments to form a running bundle of filaments, and then guiding the running bundle into contact with a ribbon of fluid so as to apply a controlled quantity of the fluid to the bundle. The fluid coated bundle is guided over a plurality of serially arranged curved braking surfaces, and it is then withdrawn by means of a draw roll so as to draw the running bundle to an extent which exceeds its plastic limit. The application of the fluid to the bundle in accordance with the present invention results in a hydrodynamic friction, rather than a sliding contact friction, between the bundle and braking surfaces, and produces yarn of very uniform quality while also avoiding wear of the braking surfaces.
Patent IE-791068-L (IE)
Title: Hydroxyimino-substituted cyclopropanecarboxylate esters,¹pesticides, and z-isomers thereof
IPC: C07D307/42
Filed: 1979-08-08
Abstract: (IR,cis)-Esters of the following general formula have pesticidal insects and acarids activity. <CHEM> wherein R<1> represents a hydrogen atom, an alkyl group containing from 1 to 10 carbon atoms optionally substituted by one or more halogen atoms, a (cycloalkyl)-alkyl group containing 3 to 7 ring carbon atoms, a total of 4 to 9 carbon atoms and optionally ring-substituted by one or more halogen atoms, a cycloalkyl group containing 3 to 7 ring carbon atoms, an alkenyl group containing 2 to 4 carbon atoms optionally substituted by one or more halogen atoms or alkynyl group containing 2 to 4 carbon atoms or an aryl group containing 6 to 12 carbon atoms or an aralkyl group containing 7 to 10 carbon atoms, each optionally ring-substituted by one or more halogen atoms; R is the residue of a pyrethroid alcohol, e.g. 3-phenoxybenzyl alcohol, alphacyano-3-phenoxybenzyl alcohol or 5-benzyl-3-furylmethyl alcohol. Of the (IR,cis)-esters, the Z-isomer form gives rise to better pesticidal activity. Novel intermediates in the form of the free acid, its salts, halides and alkyl esters are also disclosed.
Patent IE-45754-L (IE)
Title: Treatment of biodegradable material
IPC: C02F3/34
Filed: 1977-07-05
Abstract: Biodegradable organic material is treated by passing a liq. medium (esp. an aq. medium) contg. the biodegradable material upwards through a vertical treatment chamber with an aspect ratio of is not 3:1, pref. 7:1 5:1 and esp. 10-12:1, while a mainly flake shaped microorganism which is capab le of at least partially degrading the organic matl. is grown in the chamber. An oxygen-contg. gas is passed into the chamber to provide the conditions necessary for the growth of the organism, and a mixt. of treated medium, excess microorganism and gas is recovered from a common outlet at the top of the chamber. Process is an effective means of treating dilute effluents e.g. from the food industrya nd avoids the use of expensive and space-consuming activated settling tanks, biological filters and lagoons. The degraded material can be pressed into biomasses useful e.g. as food supplements for animals and man, as fertilisers and soil improvement agents.
[DE2732814A1]
Patent IE-36883-L (IE)
Title: Pipe fittings
IPC: F16L41/02
Filed: 1971-12-02
Abstract: A pipe fitting, especially a pipe junction, is formed of resilient plastics material and has sockets integrally joined by tubular necks to a hollow body, which is stiffened by longitudinal ribs extending between collars adjacent the necks and circumferential ribs connecting the longitudinal ribs, so that the load-bearing capacity is comparable with that of pipes, especially clayware pipes, which it is used to connect, without use of excessive plastics material, and yet affording allowance for the usual departures of pipe-ends from true circularity and tolerances on nominal diameter, as well as accommodating axial and/or angular misalignment over and above any between the pipes allowed for in the design of the fitting.
[US3791679A]
Patent IE-821567-L (IE)
Title: Auxiliary steerable wheels.
IPC: B62D7/14
Filed: 1982-06-30
Abstract: A device for straight traveling stabilization and change of attitude on predetermined paths for vehicle axles, comprising a permanent elastic energy loading unit which exerts on the axle stabilizing forces of a greater intensity than the external forces acting thereon, a shifting actuator which, when operated, exerts on the axle forces of greater intensity than that of the stabilizing forces and thus causes it to be steered, and a shifting actuator control member which is actuated when there are variations in the traveling attitude of the main steering system of the vehicle. The device permits the axle to which it is applied to be kept in the normal condition of a fixed axle and permits it to render steering only when the main steering system of the vehicle is subjected to steering.
[US4603873A]
Patent IE-821607-L (IE)
Title: Terpolymer resins
IPC: C08F212/12
Filed: 1982-07-01
Abstract: New terpolymer resins and a method of producing them are provided. The resins are characterised by a content of 54 to 85 weight percent of alpha-methylstyrene, 10 to 41 weight percent of styrene and 5 to 36 weight percent of isobutylene.
Patent IE-801713-L (IE)
Title: N-(3-mercapto-2-alkyl-1-oxopropyl)-2,¹3-dihydro-1h-indole-2-carboxylic acids
IPC: C07D209/42
Filed: 1980-08-13
Abstract: Disclosed herein are N-(3-mercapto-2-alkyl-1-oxopropyl)-2,3-dihydro-1H-indole-2-carboxylic acids and derivatives thereof which act as inhibitors of angiotensin converting enzyme and as anti-hypertensive agents. Derivatives include those in which the 3-mercapto group is substituted with phosphate derivatives or is replaced by a variously substituted amino group. The compounds of the invention (excluding disclosed intermediates) have the general formula: <IMAGE> wherein: n is 1 or 0; R1 is hydrogen, lower alkyl, aryl or aralkyl; R2 is hydrogen or lower alkyl; R3 is hydrogen, lower alkyl or aroyl; R5 is hydroxy, amino, or lower alkoxy; X is hydrogen, hydroxy, lower alkyl, lower alkoxy, or halogen; Y is hydrogen, lower alkyl, or aryl; R4 is -SH, <IMAGE> wherein L is O, NR7 or S (where R7 is hydrogen or lower alkyl); M is R8, OR8, or NR9R10 (where R8 is hydrogen, lower alkyl, aryl, or aralkyl; and R9 and R10 are, independently, hydrogen, lower alkyl, or aryl); A is O, NR13 or S; R11 and R12 are, independently, hydrogen, alkyl, aralkyl or aryl; R13 is hydrogen or lower alkyl; m is 0, 1, 2, or 3; R20 is hydrogen or aryl; and R21 is hydroxy or lower alkoxy; or pharmaceutically acceptable salts thereof.
[US4303583A]